Guidant warns doctors to stop implanting additional ICDs & CRT-Ds
This article was originally published in Clinica
Guidant has written to doctors warning them of a risk that a switch may become stuck in the closed position in certain of its heart rhythm management implantable devices. The company recommends doctors cease implanting the devices, as a precautionary measure, following four confirmed reports of the fault, and a fifth suspected occurrence. No patient injuries have occurred, although in the four confirmed fault reports, the devices were replaced.
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.